Clinical Trials Browser

Recruiting × Lymphoma, Follicular × Brentuximab Vedotin × Clear all

NCT04587687 2025-04-24

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular